Video

Aaron Lyss Discusses Practice Transformation Under the OCM

The Oncology Care Model (OCM) has helped practices develop their capacity to use data for continuous quality improvement, said Aaron Lyss, MBA, director of strategy and business development at Tennessee Oncology.

The Oncology Care Model (OCM) has helped practices develop their capacity to use data for continuous quality improvement, said Aaron Lyss, MBA, director of strategy and business development at Tennessee Oncology.

Transcript:

How has Oncology Care Model (OCM) participation affected practice transformation?

OCM has impacted practice transformation in I think 3 important ways. One is the MEOS payments, or care management payments, associated with the model have underwritten a lot of the investments that practices have wanted to make in improving care delivery. The second way in which OCM has influenced practice transformation is by helping practices develop the capacity to use data for continuous quality improvement, with regard to care delivery that will be important for future participation in alternative payment models. I would say the third reason why OCM has impacted practice transformation is by augmenting the capacity for practices to implement the operational activities that are going to be necessary in the future for alternative payment models. A couple examples of this would be tracking attribution to these models and understanding the stop-loss insurance market, which practices would not have had to do without participating in OCM. That will be critical for them to be capable of going forward.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Martin Engelke
David Awad, PharmD, BCOP
Dr Adela Perolla
Dr Adela Perolla | Image Credit: - stock.adobe.com
Dr Ola Landgren
Dr Ola Landgren
Andrew Kuykendall, MD, Moffitt Cancer Center
Coral Omene, MD, PhD, sitting for a vieo interview
Constance Blunt, MD, medical oncologist, Mary Bird Perkins Cancer Center
Dirk Arnold, MD, PhD, medical director, Asklepios Tumour Biology Centre
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo